Hazra, Moumita. “A Rational Pharmacotherapeutic Study of Comparative Safety Among Topical Anti-Acne 1% Nadifloxacin Monotherapy, 0.1% Adapalene Monotherapy, 0.025% Tretinoin Monotherapy, 1% Nadifloxacin and 0.1% Adapalene Combination Therapy and 1% Nadifloxacin and 0.025% Tretinoin Combination Therapy, in Mild to Moderate Acne Vulgaris, in Tertiary Care Hospitals”. International Journal of Basic & Clinical Pharmacology 8, no. 9 (August 28, 2019): 1959–1965. Accessed October 21, 2025. https://www.ijbcp.com/index.php/ijbcp/article/view/3627.